Dr Oscar Duke has spoken on BBC Morning Live about the recent concerns surrounding a popular cold and flu component, as the ...

A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...

decision to expand the use of tirzepatide to treat OSA after it filed an application back in June. Epilepsy drug sulthiame ...

Gilead Sciences, Inc. today presented the first in-depth look at full results from its pivotal Phase 3 PURPOSE 2 trial (NCT04925752), which is studying twice-yearly lenacapavir, the company's ...

Object First, the provider of Ootbi (Out-of-the-Box-Immutability), the ransomware-proof backup storage appliance purpose-built for Veeam®, today announced it continues to build momentum with year-over ...

Bioluminescence is the natural chemical process of light creation in some living creatures that makes fireflies flicker and ...

Another drug with a known mechanism of action, in the area of autoimmune diseases, is BHV-8000, a TYK2/JAK1 inhibitor in ...

We’re pleased to present the 2024 Top 50 State Lobbyists. Featured Article: Championing Inclusivity: Expanding Pathways to ...

Interestingly, despite the conventional wisdom that inflation is all but vanquished, gold reached new highs, up 13% during ...

IonQ, the Maryland-based developer of quantum computing systems that recently signed a $55 million deal with the US Air Force ...

Advancing investigation of [212Pb]VMT01 as a monotherapy and in combination with the anti-PD-1 antibody, nivolumab, in patients with previously ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...